BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Net Current Assets History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹33 Cr | ₹40 Cr | ₹41 Cr | ₹29 Cr | ₹25 Cr |
What is the latest Net Current Assets ratio of BAFNA PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹33 Cr |
Mar2024 | ₹40 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹29 Cr |
Mar2021 | ₹25 Cr |
How is Net Current Assets of BAFNA PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹33 Cr | -17.16 | |
Mar2024 | ₹40 Cr | -2.81 | |
Mar2023 | ₹41 Cr | 41.46 | |
Mar2022 | ₹29 Cr | 13.83 | |
Mar2021 | ₹25 Cr | - |
Compare Net Current Assets of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹325.5 Cr | 10.8% | 31.2% | 52.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | 10.8% |
31.2% |
52.2% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses